Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities von King, Christopher S, Dr, Nathan, Steven D, Prof

Volltext

High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success von Chandel, Abhimanyu, Patolia, Saloni, Brown, A Whitney, Collins, A Claire, Sahjwani, Dhwani, Khangoora, Vikramjit, Cameron, Paula C, Desai, Mehul, Kasarabada, Aditya, Kilcullen, Jack K, Nathan, Steven D, King, Christopher S

Volltext

Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure von King, Christopher S, Sahjwani, Dhwani, Brown, A Whitney, Feroz, Saad, Cameron, Paula, Osborn, Erik, Desai, Mehul, Djurkovic, Svetolik, Kasarabada, Aditya, Hinerman, Rachel, Lantry, James, Shlobin, Oksana A, Ahmad, Kareem, Khangoora, Vikramjit, Aryal, Shambhu, Collins, A Claire, Speir, Alan, Nathan, Steven

Volltext

Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomes von Pastre, Jean, Barnett, Scott, Ksovreli, Inga, Taylor, Jeannie, Brown, A Whitney, Shlobin, Oksana A, Ahmad, Kareem, Khangoora, Vikramjit, Aryal, Shambhu, King, Christopher S, Nathan, Steven D

Volltext

POINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? Yes von King, Christopher S., MD, FCCP, Nathan, Steven D., MD, FCCP

Volltext

Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics von Haynes, Zachary A., Chandel, Abhimanyu, King, Christopher S.

Volltext

Connective tissue disease‐associated pulmonary hypertension: A comprehensive review von Khangoora, Vikramjit, Bernstein, Elana J., King, Christopher S., Shlobin, Oksana A.

Volltext

The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment von King, Christopher S, Shlobin, Oksana A

Volltext

Rebuttal From Drs King and Nathan von King, Christopher S., MD, FCCP, Nathan, Steven D., MD, FCCP

Volltext

A New Way of Looking at an Old Problem von King, Christopher S.

Volltext

Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database von Nathan, Steven D., Barnett, Scott D., King, Christopher S., Provencher, Steeve, Barbera, Joan A., Pastre, Jean, Shlobin, Oksana A., Seeger, Werner

Volltext

Prevalence of pulmonary hypertension in patients with COVID‐19 related lung disease listed for lung transplantation: A UNOS registry analysis von Thomas, Christopher, Chandel, Abhimanyu, King, Christopher S., Aryal, Shambhu, Brown, A. Whitney, Khangoora, Vikramjit, Nyquist, Alan, Singhal, Anju, Fonseca, Onix Cantres, Shlobin, Oksana, Nathan, Steven D.

Volltext

The impact of early de novo donor specific antibodies on lung transplant outcomes: Is Timing Everything? von King, Christopher S., MD, FACP, FCCP, Cochrane, Adam B., Pharm.D., BCPS

Volltext

Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report von Stevens, Scott M, Woller, Scott C, Kreuziger, Lisa Baumann, Bounameaux, Henri, Doerschug, Kevin, Geersing, Geert-Jan, Huisman, Menno V, Kearon, Clive, King, Christopher S, Knighton, Andrew J, Lake, Erica, Murin, Susan, Vintch, Janine R E, Wells, Philip S, Moores, Lisa K

Volltext

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry von King, Christopher S., White, Emily, Aryal, Shambhu, Shlobin, Oksana A., Singhal, Anju, Brown, A. Whitney, Thomas, Christopher, Khangoora, Vikramjit, Nyquist, Alan, Flaherty, Kevin R., Nathan, Steven D., Mooney, Joshua J.

Volltext

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report von Kearon, Clive, Akl, Elie A, Ornelas, Joseph, Blaivas, Allen, Jimenez, David, Bounameaux, Henri, Huisman, Menno, King, Christopher S, Morris, Timothy A, Sood, Namita, Stevens, Scott M, Vintch, Janine R E, Wells, Philip, Woller, Scott C, Moores, Lisa

Volltext

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis von Nathan, Steven D., Tehrani, Benham, Zhao, Qiong, Arias, Rafael, Kim, Dennis, Pellegrini, Antonia, Collins, Ashley Claire, Diviney, Jack, Chakravorty, Shourjo, Khangoora, Vikramjit, Shlobin, Oksana A., Thomas, Christopher, Lavon, Ben R., King, Christopher S., Chandel, Abhimanyu

Volltext

External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis von Chandel, Abhimanyu, King, Christopher S, Ignacio, Rosalinda V, Pastre, Jean, Shlobin, Oksana A, Khangoora, Vikramjit, Aryal, Shambhu, Nyquist, Alan, Singhal, Anju, Flaherty, Kevin R, Nathan, Steven D

Volltext

Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report von Stevens, Scott M, Woller, Scott C, Baumann Kreuziger, Lisa, Bounameaux, Henri, Doerschug, Kevin, Geersing, Geert-Jan, Huisman, Menno V, Kearon, Clive, King, Christopher S, Knighton, Andrew J, Lake, Erica, Murin, Susan, Vintch, Janine R E, Wells, Philip S, Moores, Lisa K

Volltext

Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19-Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Orga... von Chandel, Abhimanyu, Puri, Nitin, Damuth, Emily, Potestio, Christopher, Peterson, Lars-Kristofer N, Ledane, Julia, Rackley, Craig R, King, Christopher S, Conrad, Steven A, Green, Adam

Volltext